title: Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis.
abstract: Malignant pleural mesothelioma (MPM) is an aggressive, asbestos-related malignancy of the thoracic pleura. Although, platinum-based agents are the first line of therapy, there is an urgent need for second-line therapies to treat the drug-resistant MPM. Cell cycle as well as apoptosis pathways are frequently altered in MPM and thus remain attractive targets for intervention strategies. Curcumin, the major component in the spice turmeric, alone or in combination with other chemotherapeutics has been under investigation for a number of cancers. In this study, we investigated the biological and molecular responses of MPM cells to curcumin treatments and the mechanisms involved. Flow-cytometric analyses coupled with western immunoblotting and gene-array analyses were conducted to determine mechanisms of curcumin-dependent growth suppression of human (H2373, H2452, H2461, and H226) and murine (AB12) MPM cells. Curcumin inhibited MPM cell growth in a dose- and time-dependent manner while pretreatment of MPM cells with curcumin enhanced cisplatin efficacy. Curcumin activated the stress-activated p38 kinase, caspases 9 and 3, caused elevated levels of proapoptotic proteins Bax, stimulated PARP cleavage, and apoptosis. In addition, curcumin treatments stimulated expression of novel transducers of cell growth suppression such as CARP-1, XAF1, and SULF1 proteins. Oral administration of curcumin inhibited growth of murine MPM cell-derived tumors in vivo in part by stimulating apoptosis. Thus, curcumin targets cell cycle and promotes apoptosis to suppress MPM growth in vitro and in vivo. Our studies provide a proof-of-principle rationale for further in-depth analysis of MPM growth suppression mechanisms and their future exploitation in effective management of resistant MPM.
authors: John D. Dingell VA Medical Center, Karmanos Cancer Institute, Wayne State University, VAMC, 4646 John R, Detroit, MI 48201, USA.
authors: Ying
authors: Y
authors: Wang
authors: Arun K
authors: AK
authors: Rishi
authors: Wenjuan
authors: W
authors: Wu
authors: Lisa
authors: L
authors: Polin
authors: Sunita
authors: S
authors: Sharma
authors: Edi
authors: E
authors: Levi
authors: Steven
authors: S
authors: Albelda
authors: Harvey I
authors: HI
authors: Pass
authors: Anil
authors: A
authors: Wali
references: Oncogene. 2001 Sep 27;20(43):6245-9
references: 11593434
references: Cancer Res. 2007 Mar 1;67(5):2351-9
references: 17332368
references: Nat Clin Pract Oncol. 2008 Mar;5(3):136-47
references: 18227828
references: Nat Rev Cancer. 2003 Oct;3(10):768-80
references: 14570043
references: Cancer Genet Cytogenet. 2006 Oct 1;170(1):9-15
references: 16965949
references: Oncol Rep. 2002 Sep-Oct;9(5):955-9
references: 12168054
references: Cancer Prev Res (Phila). 2009 Jun;2(6):525-30
references: 19470784
references: J Gastrointest Cancer. 2008;39(1-4):149-58
references: 19373441
references: Mol Cell. 2008 Aug 22;31(4):510-519
references: 18722177
references: Curr Oncol Rep. 2005 Jul;7(4):260-5
references: 15946584
references: Cancer Res. 1988 Nov 1;48(21):5941-6
references: 3139287
references: Neurochem Res. 2008 Jun;33(6):1036-43
references: 18204970
references: Anticancer Res. 2010 Jun;30(6):1947-52
references: 20651338
references: Thorac Surg Clin. 2004 Nov;14(4):489-95
references: 15559055
references: Expert Opin Emerg Drugs. 2009 Sep;14(3):423-37
references: 19552609
references: J Pathol. 2007 Mar;211(4):439-46
references: 17253597
references: Adv Enzyme Regul. 1991;31:385-96
references: 1908616
references: N Engl J Med. 2005 Oct 13;353(15):1564-73
references: 16221779
references: Mol Cancer Ther. 2007 May;6(5):1661-72
references: 17513614
references: J Biol Chem. 1994 Jan 21;269(3):2139-45
references: 8294468
references: PLoS Comput Biol. 2007 Jun;3(6):e116
references: 17604446
references: Genes Chromosomes Cancer. 1995 Feb;12(2):87-96
references: 7535092
references: Nat Cell Biol. 2001 Feb;3(2):128-33
references: 11175744
references: Ann Thorac Surg. 2006 Sep;82(3):996-1001; discussion 1001-2
references: 16928523
references: Biochem Pharmacol. 2008 Dec 1;76(11):1340-51
references: 18755156
references: Cell Mol Life Sci. 2008 Jun;65(11):1631-52
references: 18324353
references: Biochem Pharmacol. 2006 May 14;71(10):1397-421
references: 16563357
references: Cancer. 1999 Jun 15;85(12):2570-6
references: 10375104
references: Cancer Res. 2001 Aug 15;61(16):6201-12
references: 11507073
references: J Biol Chem. 2006 May 12;281(19):13188-13198
references: 16543231
references: J Biol Chem. 2009 Jul 31;284(31):20629-37
references: 19520846
references: Clin Cancer Res. 2005 Jun 15;11(12):4305-15
references: 15958611
references: Hematol Oncol Clin North Am. 2005 Dec;19(6):1117-36, vii
references: 16325127
references: Carcinogenesis. 1992 Nov;13(11):2183-6
references: 1423891
references: J Biol Chem. 2008 Aug 15;283(33):22410-6
references: 18556654
references: Clin Lung Cancer. 2003 Sep;5(2):98-106
references: 14596692
references: Cancer Chemother Pharmacol. 2010 Aug;66(3):455-66
references: 19960346
references: Cancer Chemother Pharmacol. 2011 Jun;67(6):1401-13
references: 20809119
references: J Biol Chem. 2003 Aug 29;278(35):33422-35
references: 12816952
references: Lancet Oncol. 2004 Jun;5(6):354-62
references: 15172356
references: Anticancer Res. 2005 Sep-Oct;25(5):3293-302
references: 16101141